Fabio Mangiacapra retweeted
From quadrapelegic to being back in the cath lab:
Dr. Dean Kereiakes courageously shares his journey of chronic and acute spinal cord injury caused by decades of wearing led as a stark warning to young interventional cardiologists who think they are unbreakable ... you are not
This powerful story-telling by Dean provides support to the "Ledless Movement" to protect interventional cardiologists in their literally back-breaking work
Fabio Mangiacapra retweeted
Amazing ... 🇮🇹 🇩🇪 🇵🇱 🇨🇦🇲🇦🇪🇸 🇫🇷 🇾🇪🇵🇹🇧🇪 🇦🇱 🇧🇷
Welcome to 16th edition 2VRT.PT ❗️
A big thank YOU to all our friends and colleagues ⚡️
Their expertise makes THE DIFFERENCE 🔝
ruicteles.pt/
#interventional #2VRT #Cardiology #InterventionalCardiology
#CardioTwitter
@drnvanmieghem
@KedhiElvin
@G_Tarantini01
@modine_thomas
@parma
@espogiov
@saia_francesco
@giuliamasiero3
@josepgomezlara
@pabl0salinas
@theCardioJC
@aisnptk
@sicigise
@BCIS_uk
@AGIKinterv
@jimcongress
@APIC_pt
@SACIS_KSA
@KFAFHCards
@StructuralBCN
@shci_sec
@cvnurselin
@EAPCIPresident
@RitaCal3
Meet our International Faculty!
Check out the final program at 2vrt.pt! Program the registrations at registration.2vrt.pt #HospitalSantaCruz #HospitalprofessordoutorFernandoFonseca #2VRT #interventionalcardiology #lisbon
Fabio Mangiacapra retweeted
READY FOR THE 2ND DAY OF 2VRT?
JOIN US HERE:
fb.watch/rfnYrK4C9A/
#HospitalSantaCruz #HospitalprofessordoutorFernandoFonseca #2VRT #interventionalcardiology #lisbon
Fabio Mangiacapra retweeted
PANTHER: Given its superior efficacy and similar overall safety, P2Y12 inhibitor monotherapy might be preferred over aspirin monotherapy for long-term secondary prevention. (P2Y12 Inhibitor or Aspirin Monotherapy as Secondary Prevention: authors.elsevier.com/a/1hM9L…
Fabio Mangiacapra retweeted
Novel therapy for ischaemia with no obstructive coronary arteries | European Heart Journal | @BHFCoREGlasgow @TheBHF @UKRI_News academic.oup.com/eurheartj/a…
Fabio Mangiacapra retweeted
Low-Dose Colchicine Approved for CVD: Now What? medscape.com/viewarticle/993… via @medscape
Fabio Mangiacapra retweeted
The #EAPCI Certification is designed for professionals specialising in interventional cardiology.
The programme is set out in 2️⃣parts:
1️⃣#TheExam - test the theoretical knowledge
2️⃣#TheLogbook – demonstrating the training, skills and experience
🔗: https://teapaw.org/t.co/3Nl5RvWoAl
Fabio Mangiacapra retweeted
🚨 #EuroPCR 2023 starts TOMORROW
Today #EAPCI President-Elect, Dr. Alaide Chieffo (@alaide_chief), shares:
➡️What #EAPCI means to her
➡️What her #EuroPCR highlights will be
Turn 🔊on
#JoinUs at #EAPCI
#BePartOfTheHeart🫶
Fabio Mangiacapra retweeted
#TCTAP2023
#CoronaryPhysiology
Prof Nico Pijls
The History
Fascinating to hear how we got here
Just a FEW names to know:
🩺 Andreas Grüntzig
🩺 Nico Pijls
🩺 Bernard De Bruyne
🩺 Robert Wilson
🩺 Lance Gould
🔬 Lars Tenerz
🥼 ...
#OnTheShouldersOfGiants
#DIYpressurewire
Fabio Mangiacapra retweeted
⏰ 30 minutes to go
Join @GoranEBC @stepoco for the 5th #EAPCI IC webinar
Register now https://teapaw.org/t.co/UFNlbuBLEc
@parma @FabManDoc @aayshacader @KardiologieHH @medicineinasuit @Marta33717088
Fabio Mangiacapra retweeted
#RCM - Vol. 22 No. 3
#Callforread
🎀Review - Current management and prognosis of patients with recurrent myocardial infarction
@leonardodeluca @FabManDoc
#Recurrent #myocardialinfarction #MI #ACS #management #prognosis #PCI
Full text:
imrpress.com/journal/RCM/22/…
Fabio Mangiacapra retweeted
Very sad and unbelievable news today for our community. Great gentleman, elegant, kind, nice, excellent interventional Cardiologist and scientist. Ciao Michele RIP @sicigise @EAPCIPresident @PCRonline
Fabio Mangiacapra retweeted
By fellows for fellows…a great opportunity to sharing knowledge and experience @saveriomuscoli @FabManDoc @leonardodeluca @F_prati19 #networking #Cardiology #UCBM #cardiofellows
Fabio Mangiacapra retweeted
I am fully committed to supporting the @escardio #EAPCI Board as a Training and Certification Committee chair, together with @FabManDoc
It is our great honour to coordinate the work of such experienced Committee Members.
Thank you for your trust @EAPCIPresident
Fabio Mangiacapra retweeted
#EAPCI
E - Education
A - Advocacy
P - Publications
C - Congresses
I - Innovation
A key role of #EAPCI is education & sharing our knowledge with colleagues worldwide
Meet the 2022-2024 #EAPCI Training & Certification Committee who develop & support the #EAPCI Core Curriculum
Fabio Mangiacapra retweeted
Replying to @pmhaydock
Apart from the 30% in COURAGE omt group & 25% in ISCHEMIA mot group that HAD to cross over to revasc? & all the patients excluded from ISCHEMIA with severe angina? Otherwise…
Fabio Mangiacapra retweeted
Amazing #EAPCI group at the board meeting at #ESCcongress
‼️Join as‼️
Become a member of this amazing group:
🔗 escardio.org/Marketing/EAPCI…
#StrongTogether #TeamWork
Fabio Mangiacapra retweeted
Replying to @escardio
@escardio #EAPCI Board 2022-2024 Launch & strong IC roadmap rollout.
It is a true honour to support such visionary mentors & plans
Join us to for friendship, cooperation, training, research!
@EAPCIPresident @ProfDDKardiolog @alaide_chief @WWojakowski @KardiologieHH @gabor_gt
Fabio Mangiacapra retweeted
#EAPCI friendship, handover, drawing scientific and educational future.
Board Transitional Meeting, strategic planning.
@EAPCIPresident @alaide_chief @ProfDDKardiolog @M_Lesiak @drnvanmieghem @G_Tarantini01 @WWojakowski @JSillerMatula @FabManDoc @ruict3



































